-+ 0.00%
-+ 0.00%
-+ 0.00%

Stratec SE (ETR:SBS) Just Reported Half-Year Earnings And Analysts Are Lifting Their Estimates

Simply Wall St·11/15/2026 08:14:49
Listen to the news

It's been a pretty great week for Stratec SE (ETR:SBS) shareholders, with its shares surging 12% to €27.90 in the week since its latest interim results. Overall the results were a little better than the analysts were expecting, with revenues beating forecasts by 3.2%to hit €113m. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

earnings-and-revenue-growth
XTRA:SBS Earnings and Revenue Growth November 15th 2026

Taking into account the latest results, Stratec's three analysts currently expect revenues in 2026 to be €237.7m, approximately in line with the last 12 months. The loss per share is expected to ameliorate slightly, reducing to €3.25. Before this earnings announcement, the analysts had been modelling revenues of €225.0m and losses of €3.25 per share in 2026.

Check out our latest analysis for Stratec

There were no major changes to the €27.20consensus price target despite the higher revenue estimates, with the analysts seeming to believe that ongoing losses have a larger impact on the valuation. The consensus price target is just an average of individual analyst targets, so - it could be handy to see how wide the range of underlying estimates is. The most optimistic Stratec analyst has a price target of €39.00 per share, while the most pessimistic values it at €21.00. This is a fairly broad spread of estimates, suggesting that analysts are forecasting a wide range of possible outcomes for the business.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. One thing that stands out from these estimates is that shrinking revenues are expected to moderate over the period ending 2026 compared to the historical decline of 3.1% per annum over the past five years. Compare this against analyst estimates for companies in the broader industry, which suggest that revenues (in aggregate) are expected to grow 5.6% annually. So it's pretty clear that, while it does have declining revenues, the analysts also expect Stratec to suffer worse than the wider industry.

The Bottom Line

The most obvious conclusion is that the analysts made no changes to their forecasts for a loss next year. They also upgraded their revenue estimates for next year, even though it is expected to grow slower than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Stratec going out to 2028, and you can see them free on our platform here..

And what about risks? Every company has them, and we've spotted 1 warning sign for Stratec you should know about.